Table 8.
GENE | Description |
---|---|
NIPA2 | Magnesium transporter NIPA2; Acts as a selective Mg(2+) transporter; Belongs to the NIPA family. |
ACVR1C | Activin receptor type-1C; Serine/threonine protein kinase which forms a receptor complex on ligand binding. |
SMAD2 | Mothers against decapentaplegic homolog 2; also known as SMAD family member 2; Receptor-regulated SMAD (R-SMAD) that is an intracellular signal transducer and transcriptional modulator activated by TGF-beta (transforming growth factor) and activin type 1 receptor kinases. |
ACVR1 | Activin receptor type 1; On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. |
BMP6 | Bone morphogenetic protein 6; Induces cartilage and bone formation; Bone morphogenetic proteins. |
UXS1 | UDP-glucuronic acid decarboxylase 1; Catalyzes the NAD-dependent decarboxylation of UDP- glucuronic acid to UDP-xylose. Necessary for the biosynthesis of the core tetrasaccharide in glycosaminoglycan biosynthesis. |
SMAD3 | Mothers against decapentaplegic homolog 3; also known as SMAD family member 3; Receptor-regulated SMAD (R-SMAD) that is an intracellular signal transducer and transcriptional modulator activated by TGF-beta (transforming growth factor) and activin type 1 receptor kinases. |
SMAD4 | Mothers against decapentaplegic homolog 4; also known as SMAD family member 4; In muscle physiology, plays a central role in the balance between atrophy and hypertrophy. |
CHUK | Inhibitor of nuclear factor kappa-B kinase subunit alpha; Serine kinase that plays an essential role in the NF- kappa-B signaling pathway. |
BMP5 | Bone morphogenetic protein 5; Induces cartilage and bone formation; Bone morphogenetic proteins. |
BMPR1A | Bone morphogenetic protein receptor type-1A; On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. |
BMPR2 | Bone morphogenetic protein receptor type- 2; On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. |
TGFBR1 | TGF-beta receptor type-1; Transmembrane serine/threonine kinase forming with the TGF-beta type II serine/threonine kinase receptor. Regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, and immunosuppression. |
SMAD9 | Mothers against decapentaplegic homolog 9; also known as SMAD family member 9; Transcriptional modulator activated by BMP (bone morphogenetic proteins) type 1 receptor kinase. |
BMP7 | Bone morphogenetic protein 7; Induces cartilage and bone formation. May be the osteoinductive factor responsible for the phenomenon of epithelial osteogenesis. Plays a role in calcium regulation and bone homeostasis; Bone morphogenetic proteins. |
BMPR1B | Bone morphogenetic protein receptor type-1B; On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. |
SMAD1 | Mothers against decapentaplegic homolog 1; also known as SMAD family member 1; Transcriptional modulator activated by BMP (bone morphogenetic proteins) type 1 receptor kinase. |
SMAD5 | Mothers against decapentaplegic homolog 5; also known as SMAD family member 5; Transcriptional modulator activated by BMP (bone morphogenetic proteins) type 1 receptor kinase. SMAD5 is a receptor-regulated SMAD (R-SMAD). |
ACVR1B | Activin receptor type-1B; Transmembrane serine/threonine kinase activin type-1 receptor forming an activin receptor complex with activin receptor type-2 (ACVR2A or ACVR2B). Transduces the activin signal from the cell surface to the cytoplasm and is thus regulating many physiological and pathological processes including neuronal differentiation and neuronal survival, hair follicle development and cycling. |
Source: STRING.org.